First product to be launched
Based on its superior proprietary nanotechnology platform, leon-nanodrugs has a prime position in the development of nanotechnology-based supergenerics and high-barrier...
Drug reformulation on the global stage
Based on its cutting-edge microjet reactor (MJR) technology platform, leon-nanodrugs is on its way to becoming one of the leading companies in the reformulation arena for poorly...
Multimillion cash investment injected into the global nanodrug market
Based on an €18.5-million investment, with an additional €3.0 million expected later in 2015, under the lead of TVM Capital Life Sciences, a global VC company in life...
Prime position in generics
At the forefront of innovation in the international pharmaceutical market, Leon-Nanodrugs is leading the way in supergenerics and high-barrier generics. Dr Wolfgang Beier,...
Market opportunities in nanomedicine
Leon-nanodrugs is starting the co-development business in nanomedicine, leading the way in supergenerics and high-barrier generics. Managing partner Dr Wolfgang Beier answers...
Products of leon-nanodrugs GmbH
The core business of leon is the nanotechnology–based re-formulaton of established Active Pharmaceutical Ingredients (APIs) for oral or parenteral application.
